PD‐1‐specific “Blocking” antibodies that deplete PD‐1+ T cells present an inconvenient variable in preclinical immunotherapy experiments - Polesso - 2021 - European Journal of Immunology - Wiley Online Library
Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells | BMC Cancer | Full Text
Frontiers | Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance | Nature Immunology
Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells | Scientific Reports
RecombiMAb anti-mouse PD-1 (CD279) (D265A) | Bio X Cell
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory: Molecular Therapy - Oncolytics
Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy - ScienceDirect
Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells | Scientific Reports
Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load | Scientific Reports
PD1 Antibody Selection Tool | Bio X Cell
Anti-PD-1 Neutralizing Antibody
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo | Nature Biotechnology
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD- L1 Axis - ScienceDirect
PD-1 Antibody - Cat. No. 4065 | ProSci
InVivoMAb anti-mouse PD-1 (CD279, Clone: 29F.1A12) | Bio X Cell
Mouse PD-1 Antibody AF1021: R&D Systems
anti-PD-1 (mouse), mAb (blocking) (1H10) - Order from AdipoGen Life Sciences
Synergistic anti-tumor efficacy by combination therapy of a self-assembled nanogel vaccine with an immune checkpoint anti-PD-1 antibody - RSC Advances (RSC Publishing)